Tumor necrosis factor α, its soluble receptor I, and –308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: Implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective: To study tumor necrosis factor α (TNFα) –308 gene promoter polymorphism and circulating levels of TNFα and soluble TNF receptor type I (sTNFRI) in rheumatoid arthritis (RA) patients with and without reactive amyloidosis. Methods: In a retrospective study, we examined 55 RA patients with biopsy‐proven reactive amyloidosis and 55 control RA patients without amyloidosis (matched for age, sex, rheumatoid factor titer, and RA duration). Inflammatory activity was assessed by measuring the erythrocyte sedimentation rate and C‐reactive protein level. TNFα gene promoter polymorphism was studied using polymerase chain reaction–restriction fragment length polymorphism assay. Cytokine and receptor levels were measured by enzyme‐linked immunoassays. Results: Patients with RA and amyloidosis had significantly higher TNFα and sTNFRI levels than did the control RA patients. The increased circulating levels of TNFα correlated with interleukin‐18 levels, but not with the serum amyloid A protein levels or with TNFα –308 gene promoter polymorphism (reported to be associated with high TNFα levels and certain disease susceptibilities). In the patients with RA and amyloidosis, those with anemia had significantly higher TNFα and sTNFRI levels than did those without anemia, and circulating TNFα and sTNFRI levels correlated negatively with hemoglobin concentrations. In the patients with RA and amyloidosis, those with nephropathy had significantly higher TNFα and sTNFRI levels than did those without nephropathy; in patients with isolated proteinuria (but no creatinine elevation) the TNFα level was also significantly increased, indicating that the TNFα elevation was not merely a consequence of impaired renal function. Conclusion: This study shows that circulating levels of TNFα and sTNFRI are significantly increased in RA patients with amyloidosis as compared with control RA patients without amyloidosis and that the increased levels may be implicated in the pathogenesis of certain disease manifestations, including anemia of chronic disease and renal pathology in reactive amyloidosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis
Yan, S. D., Zhu, H., Zhu, A., Golabek, A., Du, H., Roher, A., Yu, J., Soto, C., Schmidt, A. M., Stern, D., et al. (2000) · Nature Medicine · doi:10.1038/76216 · Cited by 343
Cited by
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Iron metabolism in the anemia of chronic disease
Weiss, G. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.006 · Cited by 322
Anaemia in inflammatory rheumatic diseases
Weiss, G., & Schett, G. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.183 · Cited by 146
Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
Panelli, M. C., White, R., Foster, M., Martin, B., Wang, E., Smith, K., & Marincola, F. M. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-17 · Cited by 139
“Circulating levels of TNF-α and sTNFRI have been reported to be significantly increased in rheumatoid arthritis patients with amyloidosis as those without [31] (Figure 4) and after IL2 therapy [34] (Figure 5).”
Background
Metadata
- Authors
- Maury, C. P. J., Liljeström, M., Laiho, K., Tiitinen, S., Kaarela, K., & Hurme, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2003-11
- Volume
- 48
- Issue
- 11
- Pages
- 3068-3076
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2039775379
- Cited by
- 37
- References
- 2
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor necrosis factor α, its soluble receptor I, and –308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: Implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. https://app.cochat.ai/papers/10.1002/art.11294
- The paper
- Maury, C. P. J., Liljeström, M., Laiho, K., Tiitinen, S., Kaarela, K., & Hurme, M. (2003). Tumor necrosis factor α, its soluble receptor I, and –308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: Implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis & Rheumatism. https://doi.org/10.1002/art.11294
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.